Response to “Polyradiculitis Complicating SARS-CoV-2 Vaccinations is Not Infrequent”

Abstract

Keywords

Guillain-Barre Syndrome Autoimmune Diseases of the Nervous System covid-19 SARS-CoV-2

Get full access to this article

View all access options for this article.

References

Willison

Jacobs

van Doorn

. Guillain-barre syndrome. Lancet. 2016;388(10045):717-727.

Fokke

van den Berg

Drenthen

Walgaard

van Doorn

Jacobs

. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33-43.

Kinboshi

Inoue

Kojima

, et al. Pain in the acute phase of Guillain–Barre syndrome. Neurol Clin Neurosci. 2014;2(2):50-53.

Kabore

Magy

Boukhris

Mabrouk

Lacoste

Vallat

. Contribution of corticosteroid to the treatment of pain in the acute phase of Guillain-Barré syndrome. Rev Neurol. 2004;160(8-9):821-823.

Jin

P.H.

Shin

S.C.

Dhamoon

M.S.

Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study. Muscle Nerve. 2020;62(3):327-332.

Nicholson

Goubran

Chan

Siegal

. No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Rev. 2022;56:100970.

Hanson

K.E.

Goddard

Lewis

, et al. Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the vaccine safety datalink. JAMA Network Open. 2022;5(4):e228879-e228879.